New research reveals that patients who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who end conventional diet and exercise plans.
Research printed in a prominent health publication points out that while overweight people frequently drop a large proportion of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping.
"Individuals purchasing such medications need to be aware of the potential of rapid rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.
That rate of regain implies a reversion to original mass within about 18 months.
Weighing Treatments
The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
Researchers note that individuals who shed pounds through lifestyle changes alone generally see a less rapid weight regain—perhaps 100 grams monthly—after stopping.
Explaining the Rapid Rebound
Nutrition scientists suggest the mode of action of the jabs accounts for the heightened rebound.
These medications imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone levels several times higher than the body's typical production might result in the system to produce less of its own natural GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is uncontrolled, making excessive eating a significant risk."
A Chronic Issue?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts argue that, given the high risk of relapse, the treatment is often life-long.
This perspective is echoed by drug manufacturers, who note that the results "emphasize the long-term character of obesity," akin to managing diseases like hypertension.
User Accounts
Users who have come off the jabs explain a powerful resurgence of hunger.
"It felt as if something that goes on and you're instantly starving," described a patient.
This difficulty is compounded if users have not established permanent dietary or behavioural modifications during therapy.
Growing Use
Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is higher among women than men.
- The middle-aged demographic shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers stress that while these medications are effective tools for weight loss, they are not a magic solution and long-term success relies on ongoing behavioural management.